Excitation-energy-dependent molecular beacon detects early stage neurotoxic aβ aggregates in the presence of cortical neurons

Christina E. Gulácsy, Richard Meade, Dragana A.M. Catici, Christian Soeller, G. Dan Pantos, D. Dafydd Jones, Dominic Alibhai, Mark Jepson, Ventsislav K. Valev, Jody M. Mason, Robert J. Williams, Christopher R. Pudney

Research output: Contribution to journalArticle

1 Citation (Scopus)
28 Downloads (Pure)

Abstract

There is now crucial medical importance placed on understanding the role of early stage, subvisible protein aggregation, particularly in neurodegenerative disease. While there are strategies for detecting such aggregates in vitro, there is no approach at present that can detect these toxic species associated with cells and specific subcellular compartments. We have exploited excitation-energy-dependent fluorescence edge-shift of recombinant protein labeled with a molecular beacon, to provide a sensitive read out for the presence of subvisible protein aggregates. To demonstrate the potential utility of the approach, we examine the major peptide associated with the initiation of Alzheimer's disease, amyloid β-protein (Aβ) at a patho-physiologically relevant concentration in mouse cortical neurons. Using our approach, we find preliminary evidence that subvisible Aβ aggregates are detected at specific subcellular regions and that neurons drive the formation of specific Aβ aggregate conformations. These findings therefore demonstrate the potential of a novel fluorescence-based approach for detecting and imaging protein aggregates in a cellular context, which can be used to sensitively probe the association of early stage toxic protein aggregates within subcellular compartments.

Original languageEnglish
Pages (from-to)1240-1250
Number of pages11
JournalACS Chemical Neuroscience
Volume10
Issue number3
Early online date16 Oct 2018
DOIs
Publication statusPublished - 20 Mar 2019

Keywords

  • Alzheimer's
  • amyloid beta
  • edge-shift
  • Fluorescence
  • neuron

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

Excitation-energy-dependent molecular beacon detects early stage neurotoxic aβ aggregates in the presence of cortical neurons. / Gulácsy, Christina E.; Meade, Richard; Catici, Dragana A.M.; Soeller, Christian; Pantos, G. Dan; Jones, D. Dafydd; Alibhai, Dominic; Jepson, Mark; Valev, Ventsislav K.; Mason, Jody M.; Williams, Robert J.; Pudney, Christopher R.

In: ACS Chemical Neuroscience, Vol. 10, No. 3, 20.03.2019, p. 1240-1250.

Research output: Contribution to journalArticle

@article{e3ceb398ba0f44bea1d6716661ee00df,
title = "Excitation-energy-dependent molecular beacon detects early stage neurotoxic aβ aggregates in the presence of cortical neurons",
abstract = "There is now crucial medical importance placed on understanding the role of early stage, subvisible protein aggregation, particularly in neurodegenerative disease. While there are strategies for detecting such aggregates in vitro, there is no approach at present that can detect these toxic species associated with cells and specific subcellular compartments. We have exploited excitation-energy-dependent fluorescence edge-shift of recombinant protein labeled with a molecular beacon, to provide a sensitive read out for the presence of subvisible protein aggregates. To demonstrate the potential utility of the approach, we examine the major peptide associated with the initiation of Alzheimer's disease, amyloid β-protein (Aβ) at a patho-physiologically relevant concentration in mouse cortical neurons. Using our approach, we find preliminary evidence that subvisible Aβ aggregates are detected at specific subcellular regions and that neurons drive the formation of specific Aβ aggregate conformations. These findings therefore demonstrate the potential of a novel fluorescence-based approach for detecting and imaging protein aggregates in a cellular context, which can be used to sensitively probe the association of early stage toxic protein aggregates within subcellular compartments.",
keywords = "Alzheimer's, amyloid beta, edge-shift, Fluorescence, neuron",
author = "Gul{\'a}csy, {Christina E.} and Richard Meade and Catici, {Dragana A.M.} and Christian Soeller and Pantos, {G. Dan} and Jones, {D. Dafydd} and Dominic Alibhai and Mark Jepson and Valev, {Ventsislav K.} and Mason, {Jody M.} and Williams, {Robert J.} and Pudney, {Christopher R.}",
year = "2019",
month = "3",
day = "20",
doi = "10.1021/acschemneuro.8b00322",
language = "English",
volume = "10",
pages = "1240--1250",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Excitation-energy-dependent molecular beacon detects early stage neurotoxic aβ aggregates in the presence of cortical neurons

AU - Gulácsy, Christina E.

AU - Meade, Richard

AU - Catici, Dragana A.M.

AU - Soeller, Christian

AU - Pantos, G. Dan

AU - Jones, D. Dafydd

AU - Alibhai, Dominic

AU - Jepson, Mark

AU - Valev, Ventsislav K.

AU - Mason, Jody M.

AU - Williams, Robert J.

AU - Pudney, Christopher R.

PY - 2019/3/20

Y1 - 2019/3/20

N2 - There is now crucial medical importance placed on understanding the role of early stage, subvisible protein aggregation, particularly in neurodegenerative disease. While there are strategies for detecting such aggregates in vitro, there is no approach at present that can detect these toxic species associated with cells and specific subcellular compartments. We have exploited excitation-energy-dependent fluorescence edge-shift of recombinant protein labeled with a molecular beacon, to provide a sensitive read out for the presence of subvisible protein aggregates. To demonstrate the potential utility of the approach, we examine the major peptide associated with the initiation of Alzheimer's disease, amyloid β-protein (Aβ) at a patho-physiologically relevant concentration in mouse cortical neurons. Using our approach, we find preliminary evidence that subvisible Aβ aggregates are detected at specific subcellular regions and that neurons drive the formation of specific Aβ aggregate conformations. These findings therefore demonstrate the potential of a novel fluorescence-based approach for detecting and imaging protein aggregates in a cellular context, which can be used to sensitively probe the association of early stage toxic protein aggregates within subcellular compartments.

AB - There is now crucial medical importance placed on understanding the role of early stage, subvisible protein aggregation, particularly in neurodegenerative disease. While there are strategies for detecting such aggregates in vitro, there is no approach at present that can detect these toxic species associated with cells and specific subcellular compartments. We have exploited excitation-energy-dependent fluorescence edge-shift of recombinant protein labeled with a molecular beacon, to provide a sensitive read out for the presence of subvisible protein aggregates. To demonstrate the potential utility of the approach, we examine the major peptide associated with the initiation of Alzheimer's disease, amyloid β-protein (Aβ) at a patho-physiologically relevant concentration in mouse cortical neurons. Using our approach, we find preliminary evidence that subvisible Aβ aggregates are detected at specific subcellular regions and that neurons drive the formation of specific Aβ aggregate conformations. These findings therefore demonstrate the potential of a novel fluorescence-based approach for detecting and imaging protein aggregates in a cellular context, which can be used to sensitively probe the association of early stage toxic protein aggregates within subcellular compartments.

KW - Alzheimer's

KW - amyloid beta

KW - edge-shift

KW - Fluorescence

KW - neuron

UR - http://www.scopus.com/inward/record.url?scp=85057871010&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.8b00322

DO - 10.1021/acschemneuro.8b00322

M3 - Article

VL - 10

SP - 1240

EP - 1250

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 3

ER -